Single User
£3750
PDF
50 pages

Vascular Dementia Forecast in 13 Major Markets 2017-2027


Vascular Dementia (VaD) is the second most common form of dementia after Alzheimer disease. It is also known as multi-infarct dementia (MID) and vascular cognitive impairment (VCI), and is caused by issues with blood supply to the brain, typically caused by a series of minor strokes.

This report provides the current prevalent population for Vascular Dementia across 13 Major Markets (USA, Canada, France, Germany, Italy, Spain, United Kingdom, Brazil, Japan, India, China, Republic of Korea and Russian Federation) and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Vascular Dementia have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Vascular Dementia include:

  • Stroke
  • Diabetes
  • Heart disease
  • Sleep apnoea (linked with hypertension)
  • Other dementias

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
  • Able to quantify patient populations in global Vascular Dementia market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Vascular Dementia and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Vascular Dementia prevalent population.
  • Identify sub-populations within Vascular Dementia which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Vascular Dementia patients.
Table of Contents
  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for Vascular Dementia
  • Features of Vascular Dementia patients
    • Diagnosis of VaD (ADDTC, NINCDS/ ADRDA Criteria)
    • Number of Identified Infarcts
  • Significant Comorbid Conditions associated with Vascular Dementia
    • History of stroke
    • Incident Strokes
    • White Matter Grade 3+
    • Ventricular Atrophy 5+
    • Hypertension
    • Diabetes Mellitus
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix
List of Tables
  • Prevalence of Vascular Dementia, total (000s)
  • Prevalence of Vascular Dementia, males (000s)
  • Prevalence of Vascular Dementia, females (000s)
  • Diagnosis of patients with Vascular Dementia, total (000s)
  • Number of identified ≥ 3mm infarcts in patients with Vascular Dementia, total (000s)
  • Prevalence of Strokes in patients with Vascular Dementia, total (000s)
  • Incidence of Strokes in patients with Vascular Dementia, total (000s)
  • Prevalence of White Matter Grade 3+ in patients with Vascular Dementia, total (000s)
  • Prevalence of Ventricular Atrophy 5+ in patients with Vascular Dementia, total (000s)
  • Prevalence of Hypertension in patients with Vascular Dementia, total (000s)
  • Prevalence of Diabetes Mellitus in patients with Vascular Dementia, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • USA Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • Canada Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • Canada Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • France Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • France Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • Germany Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • Germany Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • Italy Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • Italy Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • Spain Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • Spain Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • Japan Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • Japan Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • India Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • India Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • China Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • China Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • Republic of Korea Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • Republic of Korea Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
  • Russian Federation Prevalence of Vascular Dementia by 5-yr age cohort, males (000s)
  • Russian Federation Prevalence of Vascular Dementia by 5-yr age cohort, females (000s)
Brazil, Canada, China, France, Germany, India, Italy, Japan, Republic of Korea, Russian Federation, Spain, United Kingdom, United States of America